Finanças

Notícias Discussões Sinais técnicos Previsão Sazonais

Despesas operacionais (excl. CPV) de TransCode Therapeutics, Inc..

Dados anuais

2020

2021

2022

2023

TTM

‪‪−20,00 M‬‬

‪‪−15,00 M‬‬

‪‪−10,00 M‬‬

‪‪−5,00 M‬‬

‪0,00‬

Período

Valor

Variação

Variação %

TTM

‪‪−14,08 M‬‬

+‪‪4,83 M‬‬

+‪25,54‬%

2023

‪‪−18,90 M‬‬

‪‪−334,56 K‬‬

‪−1,80‬%

2022

‪‪−18,57 M‬‬

‪‪−12,46 M‬‬

‪−203,95‬%

2021

‪‪−6,11 M‬‬

‪‪−5,38 M‬‬

‪−740,71‬%

2020

‪‪−726,60 K‬‬

‪‪−269,74 K‬‬

‪−59,04‬%

Dados trimestrais

Q1 '20

Q2 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪‪−6,00 M‬‬

‪‪−4,50 M‬‬

‪‪−3,00 M‬‬

‪‪−1,50 M‬‬

‪0,00‬

Período

Valor

Variação

Variação %

Q3 '24

‪‪−2,04 M‬‬

+‪‪2,93 M‬‬

+‪59,01‬%

Q2 '24

‪‪−4,97 M‬‬

‪‪−1,82 M‬‬

‪−57,95‬%

Q1 '24

‪‪−3,15 M‬‬

+‪‪771,53 K‬‬

+‪19,69‬%

Q4 '23

‪‪−3,92 M‬‬

+‪‪1,27 M‬‬

+‪24,47‬%

Q3 '23

‪‪−5,19 M‬‬

‪‪−195,51 K‬‬

‪−3,92‬%

Q2 '23

‪‪−4,99 M‬‬

‪‪−192,33 K‬‬

‪−4,01‬%

Q1 '23

‪‪−4,80 M‬‬

+‪‪697,04 K‬‬

+‪12,68‬%

Q4 '22

‪‪−5,50 M‬‬

‪‪−569,20 K‬‬

‪−11,55‬%

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21

Q4 '20

Q3 '20

Q2 '20

Q1 '20